Relationships between Brain Natriuretic Peptide, Troponin I and QT Dispersion in Asymptomatic Dialysis Patients

REFERENCES

• Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002; 106: 2941–2945
   PubMed Web of Science ®Google Scholar
• DeFilippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003; 290: 353–359
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol. 2001; 12: 1508–1515
   PubMed Web of Science ®Google Scholar
• Naganusa T, Suguimura K, Wada S, et al. The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol. 2002; 22: 437–444
   Google Scholar
• Ljutic D, Sardelic S, Bagatin J, Pivac N, Rumboldt Z. QT interval as a marker of venous reactivity in dialysis patients. Acta Med Croatica. 1998; 52: 39–41
   Google Scholar
• Beaubien ER, Pylypchuk GB, Akhtar J, Biem HJ. Value of corrected QT interval dispersion in identifying patients initiating dialysis at increased risk of total and cardiovascular mortality. Am J Kidney Dis. 2002; 39: 834–842
   PubMed Web of Science ®Google Scholar
• Cheung BM. Plasma concentration of brain natriuretic peptide is related to diastolic function in hypertension. Clin Exp Pharmacol Physiol. 1997; 24: 966–968
   Google Scholar
• Lang CC, Prasad N, McAlpine HM, et al. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J. 1994; 127: 1635–1636
   PubMed Web of Science ®Google Scholar
• Cheung BM, Kumana CR. Natriuretic peptides: relevance in cardiovascular disease. JAMA. 1998; 280: 1983–1984
   PubMed Web of Science ®Google Scholar
• LaVecchia L, Mezzena G, Zanolla L, et al. Cardiac troponin I as a diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant. 2000; 19: 644–652
   Google Scholar
• Sato Y, Yamada T, Taniguchi R, et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation. 2001; 103: 369–374
   PubMed Web of Science ®Google Scholar
• Del Carlo CH O'Connor CM. Cardiac troponins in congestive heart failure. Am Heart J. 1999; 138: 646–653
   Google Scholar
• Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996; 335: 1342–1349
   PubMed Web of Science ®Google Scholar
• Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation. 2003; 19(108)833–838
   Google Scholar
• Franz MR, Cima R, Wang D, Profitt D, Kurz R. Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation. 1992; 86: 968–978
   PubMed Web of Science ®Google Scholar
• Wang Z, Taylor LK, Denney WD, Hansen DE. Initiation of ventricular extrasystoles by myocardial stretch in chronically dilated and failing canine left ventricle. Circulation. 1994; 90: 2022–2031
   Google Scholar
• Reiter MJ. Effects of mechano-electrical feedback: potential arrhythmogenic influence in patients with congestive heart failure. Cardiovasc Res. 1996; 32: 44–51
   Google Scholar
• Lee TM, Su SF, Wang TD, et al. Increased ventricular repolarization inhomogeneity during postural changes in patients with syndrome X. Am J Cardiol. 1998; 82: 615–620
   Google Scholar
• Bazett HC. An analysis of time-relations of the electrocardiograms. Heart. 1920; 7: 353–570
   Google Scholar
• Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med. 1997; 336: 1131–1141
   PubMed Web of Science ®Google Scholar
• Cheng W, Li B, Kajstura J, et al. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995; 96: 2247–2259
   PubMed Web of Science ®Google Scholar
• Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM. Preload induces troponin I degradation independently of myocardial ischemia. Circulation. 2001; 103: 2035–2037
   PubMed Web of Science ®Google Scholar
• Kollef MH, Ladenson JH, Eisenberg PR. Clinically recognized cardiac dysfunction: an independent determinant of mortality among critically ill patients. Chest. 1997; 111: 1340–1347
   Google Scholar
• Cardinale D, Sandri MT, Martinoni A, et al. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol. 2000; 36: 517–522
   PubMed Web of Science ®Google Scholar
• Parodi O, De Maria R, Oltrona L, et al. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation. 1993; 88: 509–522
   PubMed Web of Science ®Google Scholar
• Wang AY, Lam CW, Yu CM, et al. Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis. Kidney Int. 2006; 70: 444–452
   PubMed Web of Science ®Google Scholar
• Kantarci G, Ozener C, Tokay S, Bihorac A, Akoglu E. QT dispersion in hemodialysis and CAPD patients. Nephron. 2002; 91: 739–741
   PubMedGoogle Scholar
• Yildiz A, Akkaya V, Sahin S, et al. QT dispersion and signal-averaged electrocardiogram in hemodialysis and CAPD patients. Perit Dial Int. 2001; 21: 186–192
   PubMedGoogle Scholar
• Goldner B, Brandspiegel HZ, Horwitz L, Jadonath R, Cohen TJ. Utility of QT dispersion combined with the signal-averaged electrocardiogram in detecting patients susceptible to ventricular tachyarrhythmia. Am J Cardiol. 1995; 76: 1192–1194
   PubMed Web of Science ®Google Scholar